trial

Efficacy of Mindfulness in PREventing Progression to Psychosis in Individuals With an Ultra High Risk for Psychosis

NCTId NCT06870305
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 270 (estimated)
Sponsored by Centre Psychothérapique de Nancy
Primary completion 2029-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
270 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2029-04
Primary completion
2029-04
Eligibility
ALL · 18 Years · 30 Years

Interventions & indications

Drugs
MBTP : Mindflulness based training for psychosis

Sponsors

Centre Psychothérapique de NancyLead Sponsor

Sites

2 total
Brest, FranceLaxou, France

Facts & assertions

4 sourced
Enrollment
270
Phase
NA
Primary Completion Date
2029-04
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
MBTP : Mindflulness based training for psychosis
drug
lead_sponsor
Centre Psychothérapique de Nancy
company
indication
Clinical High Risk for Psychosis (CHR)
indication
Psychotic Disorders
indication